DPT-Hib vaccine

DPT-Hib vaccine
Combination of
Diphtheria vaccineVaccine
Tetanus vaccineVaccine
Pertussis vaccineVaccine
Hib vaccineVaccine
Names
Trade namesTetramune
Clinical data
Pregnancy
category
  • US: C (Risk not ruled out)
    Routes of
    use    		Intramuscular injection
    External links
    AHFS/Drugs.comMicromedex Detailed Consumer Information
    Identifiers
    ATC code

    DPT-Hib vaccine is a combination vaccine that protects against 4 diseases; diphtheria, tetanus, whooping cough, and Haemophilus influenzae disease.[1]

    A branded formulation was marketed in the US as Tetramune by Lederle Praxis Biologicals (subsequently acquired by Wyeth).[2] Tetramune has since been discontinued.[3][4]

    References

    1. ↑ "Diphtheria and Tetanus Toxoids and Pertussis Vaccine Adsorbed and Haemophilus B Conjugate Vaccine (Systemic)". Drugs.com. Archived from the original on 15 July 2018. Retrieved 15 July 2018.
    2. ↑ Centers for Disease Control Prevention (CDC) (April 1993). "FDA approval of use of a new Haemophilus b conjugate vaccine and a combined diphtheria-tetanus-pertussis and Haemophilus b conjugate vaccine for infants and children". MMWR. Morbidity and Mortality Weekly Report. Centers for Disease Control and Prevention. 42 (15): 296–8. PMID 8479415. Archived from the original on 25 June 2017. Retrieved 15 July 2018.
    3. ↑ "Selected Discontinued U.S. Vaccines" (PDF). Centers for Disease Control and Prevention. Archived (PDF) from the original on 23 November 2017. Retrieved 15 July 2018.
    4. ↑ Zarei AE, Almehdar HA, Redwan EM (2016). "Hib Vaccines: Past, Present, and Future Perspectives". Journal of Immunology Research. 2016: 7203587. doi:10.1155/2016/7203587. PMC 4745871. PMID 26904695. Table 1
    This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.